Cite
Frenck RW, Conti V, Ferruzzi P, et al. Efficacy, safety, and immunogenicity of the . EClinicalMedicine. 2021;39:101076doi: 10.1016/j.eclinm.2021.101076.
Frenck, R. W., Conti, V., Ferruzzi, P., Ndiaye, A. G. W., Parker, S., McNeal, M. M., Dickey, M., Granada, J. P., Cilio, G. L., De Ryck, I., Necchi, F., Suvarnapunya, A. E., Rossi, O., Acquaviva, A., Chandrasekaran, L., Clarkson, K. A., Auerbach, J., Marchetti, E., Kaminski, R. W., Micoli, F., Rappuoli, R., Saul, A., Martin, L. B., & Podda, A. (2021). Efficacy, safety, and immunogenicity of the . EClinicalMedicine, 39101076. https://doi.org/10.1016/j.eclinm.2021.101076
Frenck, Robert W, et al. "Efficacy, safety, and immunogenicity of the ." EClinicalMedicine vol. 39 (2021): 101076. doi: https://doi.org/10.1016/j.eclinm.2021.101076
Frenck RW, Conti V, Ferruzzi P, Ndiaye AGW, Parker S, McNeal MM, Dickey M, Granada JP, Cilio GL, De Ryck I, Necchi F, Suvarnapunya AE, Rossi O, Acquaviva A, Chandrasekaran L, Clarkson KA, Auerbach J, Marchetti E, Kaminski RW, Micoli F, Rappuoli R, Saul A, Martin LB, Podda A. Efficacy, safety, and immunogenicity of the . EClinicalMedicine. 2021 Aug 13;39:101076. doi: 10.1016/j.eclinm.2021.101076. eCollection 2021 Sep. PMID: 34430837; PMCID: PMC8367798.
Copy
Download .nbib